APA (7th ed.) Citation

Watchmaker, P., Crawford, J. R., Goldman, S., Whipple, N. S., Okada, H., Chi, S. N., . . . Mueller, S. (2019). PDCT-17 (LTBK-11). PNOC007: H3.3K27M SPECIFIC PEPTIDE VACCINE COMBINED WITH POLY-ICLC FOR THE TREATMENT OF NEWLY DIAGNOSED HLA-A2+ H3.3K27M MIDLINE GLIOMAS. Neuro-Oncology, 21, vi284-vi285. https://doi.org/10.1093/neuonc/noz219.1200

Chicago Style (17th ed.) Citation

Watchmaker, Payal, et al. "PDCT-17 (LTBK-11). PNOC007: H3.3K27M SPECIFIC PEPTIDE VACCINE COMBINED WITH POLY-ICLC FOR THE TREATMENT OF NEWLY DIAGNOSED HLA-A2+ H3.3K27M MIDLINE GLIOMAS." Neuro-Oncology 21 (2019): vi284-vi285. https://doi.org/10.1093/neuonc/noz219.1200.

MLA (9th ed.) Citation

Watchmaker, Payal, et al. "PDCT-17 (LTBK-11). PNOC007: H3.3K27M SPECIFIC PEPTIDE VACCINE COMBINED WITH POLY-ICLC FOR THE TREATMENT OF NEWLY DIAGNOSED HLA-A2+ H3.3K27M MIDLINE GLIOMAS." Neuro-Oncology, vol. 21, 2019, pp. vi284-vi285, https://doi.org/10.1093/neuonc/noz219.1200.